Case Study – World-Class Noise Performance

Case Study Delta Diagnostics’ world-class noise performance In label-free biosensing, noise performance is critical. A low baseline noise level is a prerequisite to detecting analytes in very low concentrations and/or to detect low-molecular-weight analytes....

read more

Seed round from PhotonDelta & TNO Investment

News Cash Infusion For Photonics-Focused Biosensor Startup Delta Diagnostics Rotterdam-based Delta Diagnostics lands seed round from PhotonDelta & TNO Investment to help bring its biosensor system to the market faster. 14 July 2022, Rotterdam – Biosensor R&D...

read more

MIT R&D grant

News MIT R&D grant Delta Diagnostics, together with project partner SensUR Health, obtained a MIT R&D grant from the Provincie Zuid-Holland for the development of a Chronic Kidney Disease test. This development will rely on a combination of the photonic...

read more

Instrument delivered to AUMC

News Instrument delivered to AUMC Delta Diagnostics delivers a prototype R&D instrument to the Amsterdam University Medical Center, where the system will be used in the NWO-funded project “Profiling information using the chemical signature of a fingermark” in...

read more

Proto Instrument Delivered

News Proto instrument delivered Delta Delivers an instrument to the department Smart Sensor Systems of the Haagse Hogeschool. The Instrument will be used for the development of assays for various applications by both Physics students and Process and Food Technology...

read more

First Prototype Delivered

News First prototype delivered Delta Diagnostics delivered its first prototype R&D instrument to the NanoBio Research Group of  Saxion Hogeschool. The instrument will among others be used in projects aimed to detect SARS-CoV-2 antigens and to detect residues of...

read more

Biomarkers In Interstitial Fluid

News Biomarkers in interstitial fluid Biotech company ImcoMET (www.imcomet.com) selects Delta Diagnostics’ instrument to measure biomarkers in interstitial fluid.

read more

CES

News CES Delta Diagnostics is present at the all-virtual Consumer Electronics Show in Vegas to showcase its innovative biosensing technololgy.

read more

Case Study – IgG Detection

Case Study Rapid Serological Testing for COVID-19 IgG Test Platform Delta Diagnostics introduces a platform that enables rapid and cost-effective development of new diagnostic tests. This platform can be employed to swiftly respond to the demand for a new test, such...

read more

Case Study – SPR

Case Study Delta Diagnostics’ label-free biosensors match the performance of high-end SPR technology at a fraction of the cost The Technology An optical chip (photonic integrated circuit) is a small silicon chip with optical waveguides on the surface. Light is...

read more

UNIIQ

News Investment UNIIQ Proof of concept fund UNIIQ invests in Delta Diagnostics, enabling the further development and validation of its innovative platform.  

read more

FastLane Project

News Fastlane Project Delta Diagnostics is one of 15 high-potential companies selected by The Netherlands Enterprise Agency RVO for its RVO Fastlane project and as part of this project receives support in the form of specialized advice from RVO in various strategic...

read more

Teknowledgy

News Teknowledgy Delta Diagnostics presents one of its early prototype analysers at the Teknowledgy – NWO Innovation Festival fare .  

read more

SME Instrument Phase 1 Granted

News SME Instrument Phase 1 Granted Delta Diagnostics has been granted the SME instrument phase 1 subsidy to further develop its business case focussing on point-of-care diagnostics.  

read more

NWO Take-Off Loan

News NWO Take-Off Loan Delta Diagnostics is granted the NWO take-off loan to develop prototypes and prove the performance of its biosensing technology for various applications.  

read more

NWO Take Off Phase 1 Granted

News NWO Take off phase 1 granted Delta Diagnostics receives the NWO take-off phase 1 subsidy to perform a feasibility study in which it is able to develop its business case.  

read more